News and Announcements
Wave Swell Energy Technology in International Publication
- Published February 12, 2020 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
An article about the Wave Swell Energy (WSE) technology has appeared in the US-based International Water Power and Dam Construction magazine (see attached), describing the technology, its benefits, and the King Island project. The latter is nearing completion and approaching its operational phase, with the first generation of electricity from the project expected by the middle of the year.
For the information of potential investors in the WSE’s current $500K capital raising round, the company has now received firm commitments for over $300K. Commitments are required by February 28, with funds to be deposited by March 13.
International Water Power and Dam Magazine
About Wave Swell Energy
WSE has developed a unique cost-effective technology to convert the energy in ocean waves into electricity. The technology involves no moving parts whatsoever in the water, thereby precluding costly underwater access for maintenance. The company is currently developing a 200 kW project at King Island, aimed at demonstrating the commercial viability of the technology.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
